Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer

M. G. Kris; R. J. Gralla; N. Martini; L. V. Stampleman; M. T. Burke

doi:10.1016/S0039-6109(16)44342-2

Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer

M. G. Kris, R. J. Gralla, N. Martini, L. V. Stampleman, M. T. Burke

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

The continued favorable results with surgery in early stage lung cancer have led many investigators to use radiation and chemotherapy to reduce the size of unresectable tumors either before or after definitive surgery. Although earlier results with both radiation and chemotherapy have been poor, the newer cisplatin-containing combination chemotherapy regimens have yielded decreased local recurrence rates when used postoperatively following a complete resection and have produced increased complete resection rates when given preoperatively to patients with locally advanced and unresectable non-small cell lung cancer at diagnosis.

Original language	English (US)
Pages (from-to)	1051-1059
Number of pages	9
Journal	Surgical Clinics of North America
Volume	67
Issue number	5
DOIs	https://doi.org/10.1016/S0039-6109(16)44342-2
State	Published - 1987
Externally published	Yes

ASJC Scopus subject areas

Surgery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0039-6109(16)44342-2

Cite this

@article{2a8ae0ab0bbe453db5320de6b2242bb4,

title = "Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer",

abstract = "The continued favorable results with surgery in early stage lung cancer have led many investigators to use radiation and chemotherapy to reduce the size of unresectable tumors either before or after definitive surgery. Although earlier results with both radiation and chemotherapy have been poor, the newer cisplatin-containing combination chemotherapy regimens have yielded decreased local recurrence rates when used postoperatively following a complete resection and have produced increased complete resection rates when given preoperatively to patients with locally advanced and unresectable non-small cell lung cancer at diagnosis.",

author = "Kris, {M. G.} and Gralla, {R. J.} and N. Martini and Stampleman, {L. V.} and Burke, {M. T.}",

note = "Funding Information: Supported in part by grant CA 05826 from the National Institutes of Health and by the TishberglMcGauley Fund. Dr. Kris is a recipient of an American Cancer Society Clinical Oncology Career Development Award.",

year = "1987",

doi = "10.1016/S0039-6109(16)44342-2",

language = "English (US)",

volume = "67",

pages = "1051--1059",

journal = "Surgical Clinics of North America",

issn = "0039-6109",

publisher = "W.B. Saunders Ltd",

number = "5",

}

TY - JOUR

T1 - Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer

AU - Kris, M. G.

AU - Gralla, R. J.

AU - Martini, N.

AU - Stampleman, L. V.

AU - Burke, M. T.

N1 - Funding Information: Supported in part by grant CA 05826 from the National Institutes of Health and by the TishberglMcGauley Fund. Dr. Kris is a recipient of an American Cancer Society Clinical Oncology Career Development Award.

PY - 1987

Y1 - 1987

N2 - The continued favorable results with surgery in early stage lung cancer have led many investigators to use radiation and chemotherapy to reduce the size of unresectable tumors either before or after definitive surgery. Although earlier results with both radiation and chemotherapy have been poor, the newer cisplatin-containing combination chemotherapy regimens have yielded decreased local recurrence rates when used postoperatively following a complete resection and have produced increased complete resection rates when given preoperatively to patients with locally advanced and unresectable non-small cell lung cancer at diagnosis.

AB - The continued favorable results with surgery in early stage lung cancer have led many investigators to use radiation and chemotherapy to reduce the size of unresectable tumors either before or after definitive surgery. Although earlier results with both radiation and chemotherapy have been poor, the newer cisplatin-containing combination chemotherapy regimens have yielded decreased local recurrence rates when used postoperatively following a complete resection and have produced increased complete resection rates when given preoperatively to patients with locally advanced and unresectable non-small cell lung cancer at diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=0023280991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023280991&partnerID=8YFLogxK

U2 - 10.1016/S0039-6109(16)44342-2

DO - 10.1016/S0039-6109(16)44342-2

M3 - Article

C2 - 2820069

AN - SCOPUS:0023280991

SN - 0039-6109

VL - 67

SP - 1051

EP - 1059

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

IS - 5

ER -

Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this